Stock Analiz

Insulet Corp. (PODD) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Insulet’s revenue went from $367M in fiscal 2016 to $2.7B in fiscal 2025, growth of about 24.9% a year.

Net income in fiscal 2025 was $247M, a net margin of 9.1%; the best year in this period was 2024 with $418M.

Over the twelve months to September 30, 2026, revenue was $3.2B and net income $429M.

Free cash flow was $378M in fiscal 2025 and positive in 3 of the 10 years shown.

The diluted share count rose 26% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $367M162017: $464M172018: $564M182019: $738M192020: $904M202021: $1.1B212022: $1.3B222023: $1.7B232024: $2.1B242025: $2.7B25$2.7B
Net income
2016: -$29M162017: -$27M172018: $3M182019: $12M192020: $7M202021: $17M212022: $5M222023: $206M232024: $418M242025: $247M25$247M
Free cash flow
2016: -$6M162017: -$32M172018: -$122M182019: -$65M192020: -$45M202021: -$180M212022: -$4M222023: $70M232024: $305M242025: $378M25$378M
EPS (diluted)
2016: $-0.48162017: $-0.46172018: $0.05182019: $0.19192020: $0.10202021: $0.24212022: $0.07222023: $2.94232024: $5.78242025: $3.4825$3.48

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$3.2B$2.7B$2.1B$1.7B$1.3B$1.1B$904M$738M$564M$464M$367M
Gross profit$2.3B$1.9B$1.4B$1.2B$806M$752M$582M$480M$370M$277M$211M
Operating income$588M$474M$309M$220M$38M$126M$52M$50M$27M-$7M-$11M
Net income$429M$247M$418M$206M$5M$17M$7M$12M$3M-$27M-$29M
EPS (diluted)$6.13$3.48$5.78$2.94$0.07$0.24$0.10$0.19$0.05$-0.46$-0.48
R&D$360M$301M$220M$205M$180M$160M$147M$132M$95M$76M$56M
Revenue growth—+30.7%+22.1%+30.0%+18.8%+21.5%+22.5%+30.9%+21.6%+26.4%+39.1%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$509M$569M$430M$146M$119M-$68M$84M$98M$36M$41M$16M
Capital spending-$249M-$192M-$125M-$76M-$123M-$112M-$129M-$164M-$157M-$74M-$22M
Free cash flow$260M$378M$305M$70M-$4M-$180M-$45M-$65M-$122M-$32M-$6M
Dividends paid—$0$0$0$0$0$0$0$0$0$0
Buybacks$300M$60M$0$0———————
Stock-based pay$82M$63M$69M$48M$41M$34M$36M$29M$38M$32M$24M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$716M$953M$704M$690M$806M$948M$376M$289M$273M$137M
Debt—$1.0B$1.4B$1.4B$1.4B$1.3B$1.1B$906M$592M$566M$333M
Equity—$1.5B$1.2B$733M$476M$556M$604M$76M$212M$158M$63M
Total assets—$3.2B$3.1B$2.6B$2.3B$2.0B$1.9B$1.1B$929M$817M$457M
Shares (diluted)69M72M74M74M70M69M66M62M61M58M57M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin71.9%71.6%69.8%68.3%61.7%68.5%64.4%65.1%65.7%59.8%57.5%
Operating margin18.4%17.5%14.9%13.0%2.9%11.5%5.7%6.8%4.9%-1.6%-2.9%
Net margin13.4%9.1%20.2%12.2%0.4%1.5%0.8%1.6%0.6%-5.8%-7.9%
FCF margin8.2%14.0%14.7%4.1%-0.3%-16.4%-5.0%-8.8%-21.6%-7.0%-1.7%
ROIC—13.7%9.3%9.7%1.6%5.6%2.1%4.1%2.2%-0.8%-2.1%
ROE—16.3%34.5%28.2%1.0%3.0%1.1%15.3%1.6%-16.9%-45.8%

Frequently asked questions

What is Insulet’s annual revenue?

$2.7B in fiscal 2025 and $3.2B over the twelve months to September 30, 2026.

How much profit does Insulet make?

Net income was $247M in fiscal 2025 (net margin 9.1%).

Is Insulet’s revenue growing?

Yes: revenue rose 30.7% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.